Solution structure of DNA containing α-OH-PdG: the mutagenic adduct produced by acrolein
暂无分享,去创建一个
[1] F. Guengerich,et al. Structure of the 1,N2-Ethenodeoxyguanosine Adduct Opposite Cytosine in Duplex DNA: Hoogsteen Base Pairing at pH 5.2† , 2008, Chemical research in toxicology.
[2] I. Minko,et al. Interstrand DNA cross-links induced by alpha,beta-unsaturated aldehydes derived from lipid peroxidation and environmental sources. , 2008, Accounts of chemical research.
[3] Robert E. Johnson,et al. Protein-template-directed synthesis across an acrolein-derived DNA adduct by yeast Rev1 DNA polymerase. , 2008, Structure.
[4] S. Hecht,et al. Detection and quantitation of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2007, Chemical research in toxicology.
[5] F. Johnson,et al. Structure and stability of duplex DNA containing the 3-(deoxyguanosin-N2-yl)-2-acetylaminofluorene (dG(N2)-AAF) lesion: a bulky adduct that persists in cellular DNA. , 2006, Chemical research in toxicology.
[6] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[7] R. Webster. In situ electrochemical-NMR spectroscopy. Reduction of aromatic halides. , 2004, Analytical chemistry.
[8] R. Carchman,et al. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. , 2004, Toxicology.
[9] Satya Prakash,et al. Replication by human DNA polymerase-iota occurs by Hoogsteen base-pairing. , 2004, Nature.
[10] I. Minko,et al. Comparative Evaluation of the Bioreactivity and Mutagenic Spectra of Acrolein-Derived α-HOPdG and γ-HOPdG Regioisomeric Deoxyguanosine Adducts , 2003 .
[11] C. Iden,et al. Synthesis of the minor acrolein adducts of 2(')-deoxyguanosine and their generation in oligomeric DNA. , 2003, Bioorganic chemistry.
[12] L. Nechev,et al. DNA interchain cross-links formed by acrolein and crotonaldehyde. , 2003, Journal of the American Chemical Society.
[13] I. Minko,et al. Comparative evaluation of the bioreactivity and mutagenic spectra of acrolein-derived alpha-HOPdG and gamma-HOPdG regioisomeric deoxyguanosine adducts. , 2003, Chemical research in toxicology.
[14] F. Johnson,et al. Mutagenesis by acrolein-derived propanodeoxyguanosine adducts in human cells. , 2002, Biochemistry.
[15] L. Nechev,et al. DNA adducts of acrolein: site-specific synthesis of an oligodeoxynucleotide containing 6-hydroxy-5,6,7,8-tetrahydropyrimido[1,2-a]purin-10(3H)-one, an acrolein adduct of guanine. , 2002, Chemical research in toxicology.
[16] L. Marnett,et al. Structure of an oligodeoxynucleotide containing a 1,N(2)-propanodeoxyguanosine adduct positioned in a palindrome derived from the Salmonella typhimurium hisD3052 gene: Hoogsteen pairing at pH 5.2. , 2002, Chemical Research in Toxicology.
[17] A. Grollman,et al. Genotoxic mechanism for the major acrolein-derived deoxyguanosine adduct in human cells. , 2002, Chemical research in toxicology.
[18] A. Grollman,et al. Responses to the Major Acrolein-derived Deoxyguanosine Adduct inEscherichia coli * , 2001, The Journal of Biological Chemistry.
[19] L. Marnett,et al. Evaluation of the Mutagenic Potential of the Principal DNA Adduct of Acrolein* , 2001, The Journal of Biological Chemistry.
[20] F. Johnson,et al. NMR Characterization of a DNA Duplex Containing the Major Acrolein-derived Deoxyguanosine Adduct γ-OH-1,-N 2-Propano-2′-deoxyguanosine* , 2001, The Journal of Biological Chemistry.
[21] L. Nechev,et al. Synthesis of nucleosides and oligonucleotides containing adducts of acrolein and vinyl chloride. , 2000, Chemical research in toxicology.
[22] C. Varaprasad,et al. Postsynthetic generation of a major acrolein adduct of 2'-deoxyguanosine in oligomeric DNA. , 1999, Journal of medicinal chemistry.
[23] A. Nishikawa,et al. Endogenous formation and significance of 1,N2-propanodeoxyguanosine adducts. , 1999, Mutation research.
[24] 中西 香爾,et al. Comprehensive natural products chemistry , 1999 .
[25] C. Santos. 7.03 – Probing DNA Structure by NMR Spectroscopy , 1999 .
[26] T Yagi,et al. Molecular analysis of mutations induced by acrolein in human fibroblast cells using supF shuttle vector plasmids. , 1998, Mutation research.
[27] L. Sayre,et al. Reaffirmation That Metabolism of Polyamines by Bovine Plasma Amine Oxidase Occurs Strictly at the Primary Amino Termini* , 1998, The Journal of Biological Chemistry.
[28] E. Niki,et al. Protein-bound acrolein: potential markers for oxidative stress. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] D. Patel,et al. NMR solution structures of stereoisometric covalent polycyclic aromatic carcinogen-DNA adduct: principles, patterns, and diversity. , 1997, Chemical research in toxicology.
[30] Jen-kun Lin,et al. Determination of aldehydic lipid peroxidation products with dabsylhydrazine by high-performance liquid chromatography , 1995 .
[31] L. Marnett,et al. 1H NMR of an oligodeoxynucleotide containing a propanodeoxyguanosine adduct positioned in a (CG)3 frameshift hotspot of Salmonella typhimurium hisD3052: Hoogsteen base-pairing at pH 5.8. , 1993, Chemical research in toxicology.
[32] B Honig,et al. The electrostatic contribution to DNA base‐stacking interactions , 1992, Biopolymers.
[33] Axel T. Brunger,et al. X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .
[34] R. Bhisey,et al. Mutagenicity of processed bidi tobacco: possible relevance to bidi industry workers. , 1991, Mutation research.
[35] P. Strickland,et al. Evidence for acrolein-modified DNA in peripheral blood leukocytes of cancer patients treated with cyclophosphamide. , 1991, Mutation research.
[36] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[37] R. Smith,et al. Acrolein mutagenicity in the V79 assay. , 1990, Carcinogenesis.
[38] V. Sklená,et al. Formation of a stable triplex from a single DNA strand , 1990, Nature.
[39] D. Patel,et al. NMR studies of DNA (R+)n.(Y-)n.(Y+)n triple helices in solution: imino and amino proton markers of T.A.T and C.G.C+ base-triple formation. , 1989, Biochemistry.
[40] D. Case,et al. A new method for refinement of macro molecular structures based on nuclear overhauser effect spectra , 1989 .
[41] R. Lavery,et al. Defining the structure of irregular nucleic acids: conventions and principles. , 1989, Journal of biomolecular structure & dynamics.
[42] C. W. Hilbers,et al. Nucleic acids and nuclear magnetic resonance. , 1988, European journal of biochemistry.
[43] C. Harris,et al. Mutagenesis of xeroderma pigmentosum fibroblasts by acrolein. , 1988, Mutation research.
[44] R Lavery,et al. The definition of generalized helicoidal parameters and of axis curvature for irregular nucleic acids. , 1988, Journal of biomolecular structure & dynamics.
[45] B. Ames,et al. Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. , 1985, Mutation research.
[46] S. Hecht,et al. Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. , 1984, Cancer research.
[47] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[48] C. Pantarotto,et al. The reaction of guanosine and 2'-deoxyguanosine with acrolein , 1983 .
[49] Pierre Plateau,et al. Exchangeable proton NMR without base-line distorsion, using new strong-pulse sequences , 1982 .
[50] D. States,et al. A two-dimensional nuclear overhauser experiment with pure absorption phase in four quadrants☆ , 1982 .
[51] G. Obe,et al. Acetaldehyde induces cross-links in DNA and causes sister-chromatid exchanges in human cells. , 1978, Mutation research.
[52] Al-Okab Ra. Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation. , 1976 .
[53] R. Alarcon. Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation. , 1976, Cancer treatment reports.